Day 1 Recap: AAD 2026

To stay informed with the latest conference insights, follow us on LinkedIn, Facebook, X, and Instagram, and subscribe to receive our eNewsletters.

Previewing the 2026 AAD Annual Meeting

Read more on how to navigate all the opportunities at this year’s AAD meeting, which starts today in Denver, Colorado.

Tapinarof Shows Measurable Itch Relief at Week 1 in Kids as Young as 2

With 80% of trial participants being children, this analysis provides some of the most robust early-response data available for a non-steroidal topical in pediatric AD.

Long-term BE HEARD Data Show Durable HiSCR Responses With Bimekizumab in HS

BE HEARD extension data underscore the importance of early diagnosis and treatment initiation to optimize long-term outcomes in hidradenitis suppurativa.

Award-Winning AAD Posters Highlight Emerging Therapies

This year’s AAD poster awards highlight studies advancing skin cancer prevention, inflammatory disease management, and complex dermatology care.

Darrell Rigel, MD, MS’s Melanoma Updates from AAD 2026

Melanoma cases keep rising, but AI-aided screening, gene profiling, and newer immunotherapies boost early diagnosis and long-term survival, according to Darrell Rigel, MD, MS.

Early Career Engagement and Innovation Take Center Stage at AAD 2026

Christopher Bunick, MD, PhD, interviews medical student Sabine Obagi on the value of conference participation, mentorship, and early exposure for aspiring dermatology clinicians at AAD 2026.

Skin of Color Society Meeting Reinforces Leadership, Mentorship, and Equity at AAD 2026

Nicole Negbenebor, MD, highlights the clinical and professional impact of community-driven education and evidence-based focus in skin of color dermatology.